Hormone-sensitive lipase (HSL) catalyzes the rate-limiting step and is considered the key enzyme for adipose tissue triacylglycerol (TAG) mobilization. It is acutely regulated by protein kinase A-mediated phosphorylation. Intracellular cAMP levels are controlled positively by catecholamines (via b-adrenoceptor) and negatively by insulin. Maximal lipolysis rate of human subcutaneous adipocytes is well correlated with the quantity of HSL mRNA or protein.
Hormone-sensitive lipase (HSL) catalyzes the rate-limiting step and is considered the key enzyme for adipose tissue triacylglycerol (TAG) mobilization. It is acutely regulated by protein kinase A-mediated phosphorylation. Intracellular cAMP levels are controlled positively by catecholamines (via b-adrenoceptor) and negatively by insulin. Maximal lipolysis rate of human subcutaneous adipocytes is well correlated with the quantity of HSL mRNA or protein.
Other adipose tissue proteins play a role in the lipolytic process. Adipocyte lipid binding protein (ALBP) which is involved in intracellular fatty acid traf®cking can associate with HSL. Perilipins control the accessibility of HSL to the lipid droplet surface. Ablation of these genes alters lipolysis in transgenic mice. Furthermore, HSL-de®cient mice are not obese and their catecholamineinduced lipolysis is decreased but not entirely abolished. The goal of this work was therefore to determine whether an increase of HSL content would have an impact on adipose tissue lipolysis.
HSL was overexpressed in adipose tissue of transgenic mice by microinjection of a 20 kb human HSL gene fragment. Human HSL mRNA and protein were detected in white and brown adipose tissues and skeletal muscles of transgenic mice (OF1 strain). Triglyceride lipase activity was doubled in visceral adipose tissue. Six weeks old transgenic males had reduced body weight (25.9 AE 0.4 g vs. 28.3 AE 0.6 g for wild-type mice; p`0.01) and visceral white adipose tissue mass (472 AE 2 mg vs. 669 AE 4 mg; p`0.01). We suspect that visceral adipose tissue was hypotrophic because the adipocyte diameter in transgenic mice was signi®catively reduced. Maximal isoproterenol-induced lipolysis in vitro was doubled in transgenic mice adipose tissue (7.1 AE 0.8 versus 3.6 AE 0.5 mmola10 6 adipocytesa90 min; p`0.01). The higher levels in plasma glycerol and free fatty acids of transgenic animals con®rmed increased lipolysis due to HSL overexpression. The data show that HSL overexpression in adipose tissue leads to enhanced lipolytic capacity. We are now investigating whether ALPB and perilipin expression is modi®ed in transgenic mice.
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Differential control of lipolysis by sympathetic nerves
AJ Hodgson
1 , C Wilkinson 1 , P Abolhasan 1 , and IJ Llewellyn-Smith INTRODUCTION There is overwhelming evidence that noradrenaline stimulates lipolysis in a variety of physiological situations, including exercise. The source of this noradrenaline is uncertain. Despite investigation for over 100 years, a recent review concluded``the exact nature of the sympathetic nervous system innervation of white adipose tissue (WAT) is not known but it may involve contact with adipocytes andaor their associated vasculature''. The density of sympathetic innervation of WAT reported has varied from dense to sparse, suggesting sampling problems in a tissue where the distribution of sympathetic ®bres is highly non-uniform. To overcome this dilemma, we used whole mounts' of intact lobes of rat retroperitoneal fat pads to map sympathetic nerves by immunohistochemistry. METHODS Full-thickness lobes of WAT up to 5 cm 2 from both sedentary rats and rats that had tenfold reduced fat stores due to wheel running were stretched and ®xed. Immunoreactivity for tyrosine hydroxylase (TH-IR), a marker for sympathetic nerves, was localised in the whole mounts with a highly sensitive avidinabiotin peroxidase method. The volume of adipocytes was estimated by measuring (using NIH image software) the area where their outline was at a maximum. RESULTS Most TH-IR nerve ®bres were associated with blood vessels, mainly arteries and arterioles. Veins and small vessels (possibly capillaries) were also sometimes innervated. Occasional varicose ®bres left the vasculature and came into close contact with adipocytes. These TH ®bres occasionally surrounded individual or small groups (3 ± 4) of adipocytes, making intimate and multiple contacts (baskets). Most adipocytes had no contact with TH-IR nerves. The size of un-innervated adipocytes was signi®cantly larger than adipocytes contacted by TH-IR ®bres (215 pL vs 133 pL, p`0.01). The pattern of TH innervation was very similar in sedentary and exercised rats, with baskets' being more conspicuous after exercise but not more numerous. Exercised rats showed a similar size difference between innervated and uninnervated adipoctyes (20.8 pL vs 9.46 pL, p`0.01).
CONCLUSION By examining whole mounts of fat tissue, we have shown that, in both exercised and sedentary rats, most adipocytes lack direct sympathetic innervation. A small proportion of adipocytes, however, is moderately to heavily innervated. Since un-innervated adipocytes receive a lower lipolytic stimulus, they are larger than innervated cells. These results suggest that a sub-population of adipocytes under direct sympathetic control supplies free fatty acids (FFA) in a coordinated fashion. Un-innervated adipocytes may 1) re®ll the innervated adipocytes, explaining extensive re-esteri®cation of FFA during basal conditions, and 2) be a source of FFA when sympathetic stimulation is high and noradrenaline over¯ows from both perivascular nerves and nerves around innervated adipocytes. Inhibitory a2 adrenoceptors may`focus' the effects of noradrenaline released by nerves to those adipocytes immediately adjacent to the arterial tree and to innervated adipocytes.
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Effect of the fatty genotype on two adipose secreted proteins The Zucker rats bear a mutation (fa) in the leptin receptor gene, leading to early-onset obesity. We have shown that adipose cells are early targets of this genetic lesion, exhibiting a genic pro®le which favors increased fat accretion before metabolic and endocrine abnormalities develop. To characterize their secretory function, we investigated the release of two secreted proteins, leptin and angotensinogen (AGE), in adipose cells from lean (Faafa) and obese (faafa) 5 week-old Zucker rats. Leptin and AGE mRNA were determined by northern blotting. Proteins were measured by radio-immunoassay (leptin) and western blotting (AGE) in media of adipose cells cultured for 24 h.
In obese versus lean adipose cells, the relative amounts of leptin mRNA per mg of total RNA was increased 5-fold, whereas AGE mRNA levels were unchanged. When increased total RNA per cell was taken into account, leptin mRNA was increased 8-fold and AGE mRNA, 1.6-fold. Leptin production over 24 h of culture amounted 2.5 in lean and 21 nga10 6 cells in obese rats (8-fold increase), while AGE production was increased 3-fold in the obese. We next tested the effect of dexamethasone, a glucocorticold known to enhance leptin and AGE gene expression in various models of adipose cells. Incubation with 100 nM dexamethasone increased leptin and AGE mRNA levels by 4 and 2-fold in the lean rat adipose cells. In obese rats, the effect of dexamethasone on leptin mRNA was reduced by half (2-fold effect). In contrast, AGE mRNA was increased 2-fold as in lean rats. Leptin and AGE release over 24 h of culture re¯ected the levels of their respective mRNA, suggesting transcriptional regulation by dexamethasone.
Our data suggest that: 1) the fa mutation induces a speci®c increase in leptin gene expression, which is not solely ascribed to increased fat cell size; 2) fat cell hypertrophy is not a determinant of altered dexamethasone effect, since leptin but not AGE production is affected in obese cells and 3) the adipose cell secretory function is not altered by the fa mutation, since both leptin and AGE are released according to their respective gene expression, whatever the genotype.
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Brown and white adipocytes are differently prone to apoptotic stimuli
A Bulbarelli
Obesity is the result of an imbalance between caloric intake and energy expenditure, associated with both increased white fat (WAT) stores and functionally atrophied brown adipose tissue (BAT). Recently, tumor necrosis factor-a (TNF-a) has been demonstrated as the only cytokine to be overproduced in WAT of obese subjects. In addition, we have demonstrated its causal role in inducing the obesity-linked BAT atrophy, mainly through apoptotic processes. These data suggest that TNF-a-induced apoptosis of brown adipocytes is involved in the pathophysiological mechanisms leading to obesity and related disorders. Furthermore, TNF-a may act as an inhibitor of adipogenesis and as a stimulant of lipid metabolism, but until now no clear evidence exists about its apoptotic effects on white adipocytes. For these reasons, we analysed the feasibility of BAT and WAT to undergo to apoptosis under different experimental conditions. We performed in vitro experiments by using cultured brown and white adipocytes treated with different TNF-a concentrations (1 pmol to 100 nM) for various periods of time (2 to 24 hours) in the presence of 10 mgaml cycloheximide (CHX). Apoptosis was visualized by DNA fragmentation, and by FACS using the FITC-Annexin V conjugated recombinant protein. This latter method is based on the binding properties of Annexin V to phosphatidilserine, that in a very early stage of apoptosis translocates from the inner lea¯et to the outer surface of the plasma membrane bilayer. Our results show that cultured white adipocytes are more resistant to apoptosis than brown adipocytes in a dose-and time-dependent manner. Interestingly, the extreme shrinkage of retroperitoneal white fat depot, which follows a 48 h fasting of mice, and in which white adipocytes loss markedly their lipid content, was not accompanied by the presence of any apoptotic cell as visualized by electronic microscopy. These preliminary results support the hypothesis that WAT is less prone to apoptotic stimuli than BAT. Further in vitro and in vivo experiments will be performed to better understand the pathophysiological meaning of this phenomenon in obesity development.
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Evaluation of human adenoviruses as an etiology of obesity in chickens 
RL

INTRODUCTION:
Infection with a human adenovirus, Ad-36, produces increased adiposity and paradoxically lower serum cholesterol (CHOL) and triglycerides (TG) in chickens, mice, and non-human primates. Antibodies to Ad-36 are associated with increased BMI and lower serum lipids in humans, and Ad-36 DNA has been isolated from human adipose tissue. The objective of this study was to determine if other adenoviruses can produce obesity and lipid changes in a chicken model. METHODS: Speci®c pathogen-free, 3 week old White Leghorn chickens (n 54) were weight matched into 4 groups. Chickens were inoculated intranasally with 0.1 ml of media (CON, N 12) or one of 3 human adenoviruses (N 14): AD-2, Ad-31, or Ad-37. Food intake and body wt were measured twice weekly. Four weeks after inoculation, the chickens were sacri®ced and blood samples were taken for CHOL and TG assays. Abdominal fat was dissected out, weighed, and the carcass frozen for later body composition analysis. RESULTS: Body weight, food intake, and CHOL were not different among groups, but visceral fat was markedly higher (p`.0009) and TG was lower (p`.004) with Ad-37. A summary follows:
CON
Ad-2 Ad-31 Ad-37 Lipoprotein lipase (LPL) is the rate-limiting enzyme for the hydrolysis of triglycerides (TG) from circulating TG ± rich lipoproteins and the subsequent uptake of released free fatty acids (FFA) into extrahepatic tissues. Transgenic mice lacking LPL in adipose tissue (AT) and moderately overexpressing LPL in muscle tissue have decreased TG and FFA and increased glucose plasma levels. These mice produce normal AT mass accompanied by a substantial decrease of polyunsaturated fatty acids (PUFA) in the AT lipid moiety. We addressed the question whether AT can produce a suf®cient TG pool endogenously by using carbohydrates as substrate. We determined plasma glucose levels, glucose uptake into fat pads, the rate of FFA de novo biosynthesis and lipogenic enzyme activities as well as the plasma levels of leptin, insulin and glucagon. 14 C-Deoxyglucose uptake into fat pads using ex vivo AT from fastedarefed mice was 2.5-fold induced (p`0.001) in AT-LPL-de®cient mice compared to control mice. The insulin:glucagon ratio in the plasma of fastedarefed mice was approximately 3-fold elevated (p`0.01) in comparison to control plasma levels. The rate of FFA de novo biosynthesis which was measured in fastedarefed control and AT-LPL-de®cient mice using 3 H 2 O as tracer showed a signi®cant 3.5-fold induction (p`0.01) in LPL-de®cient AT compared to control AT. Lipogenic enzyme activites in tissue homogenates showed an approximately 2.5-fold induction in AT lacking LPL compared to control littermates. However, leptin plasma levels as well as leptin mRNA expression were signi®cantly downregulated in AT-LPL-de®cient mice and we found the SREBP-1 mRNA level to be approx. 3-fold induced in LPL-de®cient AT compared to control AT.
Taken togheter our ®ndings we suggest that decreased leptin activity in addition to the lack of PUFA in AT-LPL-de®cient mice upregulates SREBP-1 which induces lipogenic enzymes to endogenously produce TG by utilizing the excess glucose levels.
